Back to search

Petreatment with Rituximab Reduces the Incidence of Chronic Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation in Patients with B Cell Lymphoma.

Martin Bornhaeuser, Rainer Schwerdtfeger, Mathias Hänel, Frank Kroschinsky, Uli Treptow
DOI: 10.1182/blood.v104.11.1233.1233
Blood

Data up to Jan 2025

Published2004
Citations4
References0
Fields
MedicineInternal medicineGastroenterologyImmunology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

Petreatment with Rituximab Reduces the Incidence of Chronic Graft-Versus-Host Disease… (2004) – Blood | Metascience Observatory Explorer